On 14 November, the UK Government confirmed that it would continue to recognise the CE marking in Great Britain for another two years (until 31 December 2024) giving businesses extra time to prepare for the mandatory introduction of the UK Conformity Assessed (UKCA) marking. Businesses can continue to use the new UKCA marking voluntarily until then, giving them flexibility to choose which marking to apply.

The UKCA marking announcement covers most types of goods which previously required the CE marking. Businesses have been able to use the UKCA mark voluntarily since 1 January 2021 to demonstrate their conformity with product standards in England, Scotland and Wales. This latest announcement follows on from the MHRA’s recent announcement that the implementation of the future UK Medical Device Regulations will be pushed back from 1 July 2023 to 1 July 2024, meaning that CE-marked medical devices will continue to be accepted in Great Britain and that medical device manufacturers will only be required to obtain a UKCA mark from July 2024 (see further details here).

Author

Adeel Haque is an Associate in Baker McKenzie's London office. Adeel qualified in September 2019 and has spent time working in the Firm's Hong Kong office. He advises clients on international trade (trade sanctions and export controls), competition, product regulatory, environmental, anti-bribery and corruption and customs law issues.

Author

Rachel MacLeod is an Associate in Baker McKenzie's London office. She advises companies on the "cradle-to-grave" regulation of a broad range of products sold on the EU and UK markets and also advises companies on how to comply with their operational environmental and health & safety obligations.

Author

Graham Stuart is a partner in Baker McKenzie's London office specialising in product regulation and environmental, health and safety law. Graham advises on the regulation of pharmaceuticals, medical devices, chemicals, food, and a wide range of consumer and industrial products, acting for clients in connection with global integrations and reorganisations; product manufacturing, marketing, supply and distribution; EU and UK product authorisation regimes; non-conformities, regulatory investigations and prosecutions. His practice also covers operational environmental, health and safety matters for industrial and manufacturing facilities; the assessment and management of environmental risk in complex multi-jurisdictional projects, mergers and acquisitions; and climate change law and emissions trading.